You can and there’s lots of research trying exactly this. Two problems though, it has very low in-vivo efficiency, so getting the plasmid to the cells is hard. And basically if you don’t kill a vast majority of cancer cells they will come back, so that’s a fundamental problem that needs to be solved. The other issue is the off-target rate. Something like 60% have at least one off-target splice and can have up to three off target splices. This can obviously be fatal to cells or exacerbate cancer.
Latest Answers